Trial NCT02929576

View at ClinicalTrials.gov 
Org. Study IDs: MDV3100-20
Secondary IDs: 2016-000796-25

Last trial update was posted on 2018-10-22

MeSH Interventions

Paclitaxel

MeSH Conditions

Breast Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

Further understanding about the role of androgen signaling in TNBC was required

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID